What is Tonix Pharmaceuticals Holding 12-1 Month Momentum %?
12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-05-12), Tonix Pharmaceuticals Holding's 12-1 Month Momentum % is -90.90%.
The industry rank for Tonix Pharmaceuticals Holding's 12-1 Month Momentum % or its related term are showing as below:
TNXP's 12-1 Month Momentum % is ranked worse than 95.69% of 1486
companies
in the Biotechnology industry
Industry Median: -22.355
vs TNXP: -90.90
Competitive Comparison of Tonix Pharmaceuticals Holding's 12-1 Month Momentum %
For the Biotechnology subindustry, Tonix Pharmaceuticals Holding's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tonix Pharmaceuticals Holding's 12-1 Month Momentum % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Tonix Pharmaceuticals Holding's 12-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Tonix Pharmaceuticals Holding's 12-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Tonix Pharmaceuticals Holding 12-1 Month Momentum % Related Terms
Thank you for viewing the detailed overview of Tonix Pharmaceuticals Holding's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.
Tonix Pharmaceuticals Holding (Tonix Pharmaceuticals Holding) Business Description
Tonix Pharmaceuticals Holding Corp is a clinical-stage biopharmaceutical company focused on developing therapeutics and vaccines to treat and prevent human disease and alleviate suffering. its portfolio consists of the central nervous system, rare disease, immunology, and infectious disease product candidates. The CNS portfolio includes small molecules and biologics to treat pain, neurologic, psychiatric, and addiction conditions. CNS product candidate is TNX-102 SL, a proprietary sublingual tablet formulation of cyclobenzaprine (CBP) designed for bedtime administration.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TNXP has been successfully added to your